Novo Nordisk Unveils Discount Plan to Challenge Obesity Drug Rivals
Novo Nordisk is stepping up its competitive game in the obesity-drug market by introducing a new discounted…
Analysis-Obesity market sales potential tightens as Novo and Lilly enter new era
By Maggie Fick, Bhanvi Satija and Mariam Sunny LONDON, Feb 2 (Reuters) – The long-held Wall Street expectation…